Home Blood Pressure Monitoring Project
HBPM
1 other identifier
interventional
348
1 country
1
Brief Summary
The goal of this project is to improve hypertension control at Kaiser Permanente Colorado (KPCO) by implementing a population-based multi-factorial intervention that uses home BP monitors that can download BP readings to KPCO's health records via internet, interactive voice response (IVR) technology, and multidisciplinary care team. Participants will be randomized to either the home blood pressure monitoring group receiving the multi-factorial intervention or the usual care group who will be receiving Kaiser standard of care. We will determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines. The study hypothesis is that a higher proportion of patients with uncontrolled hypertension in the home blood pressure monitoring (HBPM) group will achieve their target blood pressure compared to those in the usual care (UC) group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jul 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 13, 2010
CompletedFirst Posted
Study publicly available on registry
July 15, 2010
CompletedApril 6, 2012
April 1, 2012
2 years
July 13, 2010
April 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BP at 6 months
6 months
Study Arms (2)
Usual Care
NO INTERVENTIONThe control group receiving usual care
Home Blood Pressure Monitoring Group
EXPERIMENTALIntervention group
Interventions
Home blood pressure readings are taken at least 3 times a week, uploaded to a Microsoft Health Vault account through American Heart Association Heart360 at least 1 time per week. Patients are followed by a clinical pharmacist, with physician oversight, who will make adjustments to antihypertensive medications or suggest additional medications using national JNC VII and KPCO hypertension guidelines.
Eligibility Criteria
You may qualify if:
- Age 18 to 85 years At least 1 diagnosis for hypertension,
- Receive primary care from one of the participating clinics,
- The two most recent BPs documented within that last 24 months are elevated (SBP\>140 and/or DBP\>90)
- Receiving \< 3 antihypertensive medications, and
- Have access to a computer with a USB port.
You may not qualify if:
- Pregnant, or breast-feeding,
- Patients on dialysis or being followed by nephrology,
- Patients with coronary artery disease, given these patients are already followed by the Clinical Pharmacy Cardiac Risk Service (CPCRS),
- On KPCO "Do Not Call" or deceased list,
- PCP does not give permission to include patient in the study,
- BP is at or below target at the baseline study visit,
- Not English-speaking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- American Heart Associationcollaborator
Study Sites (1)
Kaiser Permanente Colorado, Institute of Health Research
Denver, Colorado, 80231, United States
Related Publications (1)
Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):157-63. doi: 10.1161/CIRCOUTCOMES.112.968172. Epub 2013 Mar 5.
PMID: 23463811DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David J Magid, MD, MPH
Kaiser Permanente
- PRINCIPAL INVESTIGATOR
Kari Olson, PharmD
Kaiser Permanente
- PRINCIPAL INVESTIGATOR
Sarah J Billups, PharmD
Kaiser Permanente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2010
First Posted
July 15, 2010
Study Start
July 1, 2008
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
April 6, 2012
Record last verified: 2012-04